Lupkynis is a medicine used to treat lupus nephritis, a manifestation of a disease called systemic lupus erythematosus. In lupus nephritis, the immune system (the body’s natural defences) attacks the kidneys, causing inflammation and kidney damage. Lupkynis is used together with another medicine called mycophenolate mofetil in adults with active class III, IV or V lupus nephritis, which are severe forms of the condition. Lupkynis contains the active substance voclosporin.
Therapeutic Indication
Lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class III, IV or V (including mixed class III/V and IV/V) lupus nephritis (LN).
Therapeutic Area (MeSH)
ATC Code
L04AD03
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
EMA Name
Lupkynis
Medicine Name
Lupkynis
Aliases
N/ANo risk management plan link.
